Concord Drugs standalone net profit rises 305.88% in the June 2021 quarter

Sales rise 11.10% to Rs 20.22 crore

Net profit of Concord Drugs rose 305.88% to Rs 0.69 crore in the quarter ended June 2021 as against Rs 0.17 crore during the previous quarter ended June 2020. Sales rose 11.10% to Rs 20.22 crore in the quarter ended June 2021 as against Rs 18.20 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales20.2218.20 11 OPM %11.285.27 -PBDT1.340.54 148 PBT0.810.22 268 NP0.690.17 306

Powered by Capital Market - Live News